SCHEMBL6174445

SCHEMBL6174445

CCN(CC)CCOC(=O)Nc1cc(C(C)C2NC(=O)N(c3ccc(SC(F)(F)F)cc3)C2=O)ccn1

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 16/20 0.43
MCHR1 Q99705 1/20 0.33
PDE2A O00408 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6175093 0.90 IGF1R (0.44) IGF1RPDE2A
SCHEMBL6177171 0.90 IGF1R (0.46) IGF1RPDE2A
SCHEMBL6175310 0.89 MCHR1 (0.35) MCHR1PDE2A
SCHEMBL6174416 0.88 IGF1R (0.33) IGF1R
SCHEMBL6177806 0.83 IGF1R (0.43) IGF1RPDE2A
SCHEMBL6172178 0.83 IGF1R (0.33) IGF1RMCHR1
SCHEMBL6174760 0.80 IGF1R (0.41) IGF1RPDE2A
SCHEMBL6174018 0.80 SLC5A1 (0.36) IGF1RPDE2A
SCHEMBL6176013 0.80 IGF1R (0.41) IGF1RPDE2A
SCHEMBL6175275 0.80 IGF1R (0.41) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed